SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular Carcinoma

NCT04297202 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Apatinib Combined With SHR-1210 Injection

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]